Medicare Enrolled
Dr. Edward Pearson, MD
Internal Medicine · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pearson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pearson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pearson
Dr. Edward Pearson is an internal medicine specialist in Dallas, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Pearson performed 47,188 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Pearson received a total of $726,673 from 62 pharmaceutical and/or device companies across 943 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pearson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 1% volume in TX
$726,673 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗47,188
Medicare services
Top 1% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
14,980 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 7,400 | $43 | $136 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,400 | $0 | $5 |
| Paclitaxel chemotherapy injection | 5,322 | $0 | $8 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,981 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,004 | $0 | $1 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
964 | $10 | $64 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
939 | $6 | $31 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
916 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
890 | $8 | $36 |
| Anti-nausea injection (Aloxi/palonosetron) | 620 | $1 | $114 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
522 | $17 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
471 | $94 | $368 |
| Injection, granisetron hydrochloride, 100 mcg | 420 | $0 | $24 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
267 | $13 | $60 |
| Iron level test | 265 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
265 | $9 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
246 | $61 | $250 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
201 | $23 | $157 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
190 | $6 | $34 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
186 | $4 | $22 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
169 | $11 | $96 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
164 | $105 | $707 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
158 | $2 | $300 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
151 | $12 | $108 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
141 | $137 | $496 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
112 | $2 | $13 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
91 | $35 | $143 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
85 | $94 | $357 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
75 | $9 | $56 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
61 | $1 | $7 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
53 | $62 | $247 |
| New patient office visit, complex (60-74 min) | 50 | $168 | $709 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
47 | $1 | $8 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
41 | $52 | $344 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
38 | $58 | $821 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
36 | $4 | $25 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
34 | $23 | $161 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
32 | $51 | $313 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
31 | $184 | $1,067 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
28 | $56 | $211 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
20 | $16 | $94 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 20 | $86 | $657 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
20 | $2 | $19 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
17 | $4 | $23 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
14 | $1,103 | $4,802 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
14 | $15 | $100 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
14 | $81 | $500 |
| X-ray of upper arm, minimum of 2 views An X-ray imaging test of the upper arm that captures at least two different views to evaluate the bones and surrounding structures. |
12 | $20 | $67 |
| Complete x-ray of body bones An x-ray imaging procedure that captures images of the entire skeletal system. |
11 | $54 | $207 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.0% high complexity
84.6% medium
14.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$726,673
Total received (2018-2024)
Avg $103,810/year across 7 years
Top 0% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
943
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$202,256
2023
$206,621
2022
$144,636
2021
$95,592
2020
$55,394
2019
$15,180
2018
$6,994
Payments by company (2024)
GENZYME CORPORATION
$75,036
Blueprint Medicines Corporation
$18,722
GlaxoSmithKline, LLC.
$18,702
Genmab U.S., Inc.
$16,962
Incyte Corporation
$13,630
Rigel Pharmaceuticals, Inc.
$12,851
ABBVIE INC.
$11,140
AstraZeneca Pharmaceuticals LP
$9,180
PharmaEssentia USA Corporation
$6,510
SERVIER PHARMACEUTICALS LLC
$5,919
Adaptive Biotechnologies Corporation
$5,446
Lilly USA, LLC
$3,663
E.R. Squibb & Sons, L.L.C.
$1,998
Celgene Corporation
$1,500
Astellas Pharma US Inc
$138
Janssen Biotech, Inc.
$137
ADC Therapeutics America, Inc.
$110
PFIZER INC.
$88
Karyopharm Therapeutics Inc.
$86
Novartis Pharmaceuticals Corporation
$81
Merck Sharp & Dohme LLC
$62
SOBI, INC
$54
Kite Pharma, Inc.
$51
Mirati Therapeutics, Inc.
$39
Regeneron Healthcare Solutions, Inc.
$30
Emmaus Medical, Inc.
$26
Legend Biotech USA Inc.
$25
Stemline Therapeutics Inc.
$25
BeiGene USA, Inc.
$23
Daiichi Sankyo Inc.
$21
Top 3 companies account for 55.6% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$206,839
AstraZeneca Pharmaceuticals LP
$127,252
E.R. Squibb & Sons, L.L.C.
$68,437
PharmaEssentia USA Corporation
$50,423
Adaptive Biotechnologies Corporation
$32,449
Astellas Pharma US Inc
$26,784
GlaxoSmithKline, LLC.
$26,127
Rigel Pharmaceuticals, Inc.
$23,562
Blueprint Medicines Corporation
$21,011
Incyte Corporation
$18,171
Celgene Corporation
$17,118
Genmab U.S., Inc.
$17,049
ABBVIE INC.
$16,623
ADC Therapeutics America, Inc.
$12,676
Lilly USA, LLC
$11,799
SERVIER PHARMACEUTICALS LLC
$7,599
Agios Pharmaceuticals, Inc.
$6,894
Servier Pharmaceuticals LLC
$6,710
Bayer HealthCare Pharmaceuticals Inc.
$4,380
Janssen Biotech, Inc.
$2,853
Karyopharm Therapeutics Inc.
$2,488
Stemline Therapeutics Inc.
$2,425
Hoffmann-La Roche Limited
$2,263
Janssen Scientific Affairs, LLC
$2,020
AbbVie Inc.
$1,800
Seattle Genetics, Inc.
$1,548
Novartis Pharmaceuticals Corporation
$1,526
Epizyme, Inc.,
$1,458
PFIZER INC.
$1,318
NOVARTIS PHARMACEUTICALS CORPORATION
$1,169
BeiGene, Ltd.
$450
Pharmacyclics LLC, An AbbVie Company
$304
Seagen Inc.
$288
Takeda Pharmaceuticals U.S.A., Inc.
$263
Amgen Inc.
$252
BeiGene USA, Inc.
$233
Kite Pharma, Inc.
$226
SANOFI-AVENTIS U.S. LLC
$211
Jazz Pharmaceuticals Inc.
$200
MorphoSys, US Inc.
$164
SOBI, INC
$135
Emmaus Medical, Inc.
$130
CTI BioPharma Corp.
$116
Dova Pharmaceuticals
$93
Acrotech Biopharma LLC
$91
JAZZ PHARMACEUTICALS INC.
$87
Ipsen Biopharmaceuticals, Inc
$70
Siemens Medical Solutions USA, Inc.
$63
Merck Sharp & Dohme LLC
$62
Mirati Therapeutics, Inc.
$59
RECORDATI_RARE_DISEASES_INC.
$57
Regeneron Healthcare Solutions, Inc.
$55
Genentech USA, Inc.
$52
Genentech, Inc.
$50
Daiichi Sankyo Inc.
$46
Sobi, Inc
$41
Legend Biotech USA Inc.
$25
Apellis Pharmaceuticals, Inc.
$24
Acrotech Biopharma Inc.
$17
Taiho Oncology, Inc.
$14
Acceleron Pharma, Inc.
$13
Gilead Sciences, Inc.
$12
Top 3 companies account for 55.4% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ALPROLIX · AYVAKIT · Aliqopa · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CARVYKTI · CRESEMBA · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENJAYMO · EPKINLY · Empaveli · Endari · Epkinly · GAMIFANT · Gamifant · ICLUSIG · IMBRUVICA · Imbruvica · JAKAFI · JAYPIRCA · KEYTRUDA · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LYNPARZA · Lunsumio · MONJUVI · MYLOTARG · Molecular Accessories · Molecular Reagents/Test Kit/Clinical Utilization · NINLARO · Neulasta · Non-Covered Product · Nplate · OJJAARA · ONUREG · PROMACTA · Polivy · Pomalyst · REBLOZYL · RETEVMO · REZUROCK · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SYLVANT · TAGRISSO · TASIGNA · TAZVERIK · TIBSOVO · Tavalisse · Tazverik · Tibsovo · VENCLEXTA · VONJO · VYXEOS · Vanflyta · Vonjo · XOSPATA · XPOVIO · Xospata · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
2,123
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pearson is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pearson experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Pearson performed 14,980 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Pearson receive payments from pharmaceutical companies?
Yes. Dr. Pearson received a total of $726,673 from 62 companies across 943 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pearson's costs compare to other internal medicine physicians in Dallas?
Dr. Pearson's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pearson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Dallas
Browse internal medicine physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology